Skip to search
Skip to main content
Back to Search
Start Over
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial
Authors :
Poli Van Creveldkliniek Medisch Coppens, Michiel Pipe, Steven W. Miesbach, Wolfgang Astermark, Jan Recht, Michael van der Valk, Paul Ewenstein, Bruce Pinachyan, Karen Galante, Nicholas Le Quellec, Sandra Monahan, Paul E. Leebeek, Frank W.G. HOPE-B Investigators Poli Van Creveldkliniek Medisch Coppens, Michiel Pipe, Steven W. Miesbach, Wolfgang Astermark, Jan Recht, Michael van der Valk, Paul Ewenstein, Bruce Pinachyan, Karen Galante, Nicholas Le Quellec, Sandra Monahan, Paul E. Leebeek, Frank W.G. HOPE-B Investigators
Publication Year :
2024
Details
Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1450185718
Document Type :
Electronic Resource